Locust Wood Capital Advisers LLC Sells 3,820 Shares of STERIS plc (NYSE:STE)

Locust Wood Capital Advisers LLC lessened its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 255,691 shares of the medical equipment provider's stock after selling 3,820 shares during the period. STERIS accounts for 1.8% of Locust Wood Capital Advisers LLC's holdings, making the stock its 25th biggest holding. Locust Wood Capital Advisers LLC owned about 0.26% of STERIS worth $52,560,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Avalon Trust Co bought a new stake in shares of STERIS in the 4th quarter valued at $30,000. Human Investing LLC bought a new stake in shares of STERIS during the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC raised its holdings in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC raised its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

Remove Ads

STERIS Price Performance

STE stock traded down $2.75 during mid-day trading on Tuesday, hitting $221.26. 88,519 shares of the stock were exchanged, compared to its average volume of 532,916. The stock has a market capitalization of $21.74 billion, a price-to-earnings ratio of 46.98 and a beta of 0.87. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The business has a fifty day moving average price of $222.67 and a 200 day moving average price of $219.40.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. STERIS's payout ratio is presently 48.41%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on STE. Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, Stephens reaffirmed an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, STERIS has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.